

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.57683916 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.01438275 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.01438275 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.00697469 |
| 5 | intestinal epithelial cell development (GO:0060576) | 4.89695155 |
| 6 | auditory receptor cell differentiation (GO:0042491) | 4.63408987 |
| 7 | signal peptide processing (GO:0006465) | 4.46095717 |
| 8 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.32612373 |
| 9 | magnesium ion transport (GO:0015693) | 4.24811799 |
| 10 | neural tube formation (GO:0001841) | 4.09128299 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.01058418 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 3.91792596 |
| 13 | regulation of protein glycosylation (GO:0060049) | 3.87371064 |
| 14 | prenylation (GO:0097354) | 3.85619632 |
| 15 | protein prenylation (GO:0018342) | 3.85619632 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.84423611 |
| 17 | interkinetic nuclear migration (GO:0022027) | 3.78578402 |
| 18 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.74280203 |
| 19 | branched-chain amino acid catabolic process (GO:0009083) | 3.73948089 |
| 20 | establishment of protein localization to Golgi (GO:0072600) | 3.71339178 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.70576887 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.70576887 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.70576887 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.70576887 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.70576887 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.70576887 |
| 27 | regulation of interferon-alpha production (GO:0032647) | 3.68547307 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.67596378 |
| 29 | negative regulation of mast cell activation (GO:0033004) | 3.63669874 |
| 30 | NIK/NF-kappaB signaling (GO:0038061) | 3.61711917 |
| 31 | T-helper 1 type immune response (GO:0042088) | 3.47143060 |
| 32 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.44507692 |
| 33 | cellular response to zinc ion (GO:0071294) | 3.40586702 |
| 34 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.40451360 |
| 35 | positive regulation of interleukin-12 production (GO:0032735) | 3.37625617 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.36515823 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.32903320 |
| 38 | protein targeting to vacuole (GO:0006623) | 3.29546849 |
| 39 | protein targeting to lysosome (GO:0006622) | 3.29546849 |
| 40 | establishment of protein localization to vacuole (GO:0072666) | 3.29546849 |
| 41 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.29209680 |
| 42 | natural killer cell mediated immunity (GO:0002228) | 3.29209680 |
| 43 | DNA demethylation (GO:0080111) | 3.27474196 |
| 44 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.27345917 |
| 45 | prostate gland growth (GO:0060736) | 3.25989251 |
| 46 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.24675071 |
| 47 | myeloid dendritic cell differentiation (GO:0043011) | 3.22023662 |
| 48 | positive regulation of antigen processing and presentation (GO:0002579) | 3.21039538 |
| 49 | iron ion import (GO:0097286) | 3.19139195 |
| 50 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.19101843 |
| 51 | myeloid dendritic cell activation (GO:0001773) | 3.17203591 |
| 52 | protein targeting to Golgi (GO:0000042) | 3.15679132 |
| 53 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.15652943 |
| 54 | ketone body metabolic process (GO:1902224) | 3.15179981 |
| 55 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.15110771 |
| 56 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.12321002 |
| 57 | positive regulation of interferon-beta production (GO:0032728) | 3.12202540 |
| 58 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.12088792 |
| 59 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.11649151 |
| 60 | lipid translocation (GO:0034204) | 3.11447880 |
| 61 | phospholipid translocation (GO:0045332) | 3.11447880 |
| 62 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.08617735 |
| 63 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.08203561 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 3.07996341 |
| 65 | Golgi to endosome transport (GO:0006895) | 3.06428217 |
| 66 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.06233170 |
| 67 | hair cell differentiation (GO:0035315) | 3.05853749 |
| 68 | sulfate transmembrane transport (GO:1902358) | 3.05010385 |
| 69 | response to pheromone (GO:0019236) | 3.04734744 |
| 70 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.04341850 |
| 71 | early endosome to late endosome transport (GO:0045022) | 3.02806613 |
| 72 | growth hormone receptor signaling pathway (GO:0060396) | 3.02267557 |
| 73 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.01713683 |
| 74 | regulation of B cell differentiation (GO:0045577) | 3.01500955 |
| 75 | neutrophil activation (GO:0042119) | 2.99742171 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 2.97379645 |
| 77 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96964129 |
| 78 | response to type I interferon (GO:0034340) | 2.96841127 |
| 79 | type I interferon signaling pathway (GO:0060337) | 2.96383203 |
| 80 | cellular response to type I interferon (GO:0071357) | 2.96383203 |
| 81 | replication fork processing (GO:0031297) | 2.96274127 |
| 82 | DNA integration (GO:0015074) | 2.96032200 |
| 83 | histone mRNA catabolic process (GO:0071044) | 2.95136368 |
| 84 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.94854792 |
| 85 | branched-chain amino acid metabolic process (GO:0009081) | 2.94757793 |
| 86 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.93607640 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93333309 |
| 88 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.92551127 |
| 89 | response to peptidoglycan (GO:0032494) | 2.91164097 |
| 90 | B cell mediated immunity (GO:0019724) | 2.90358824 |
| 91 | rRNA catabolic process (GO:0016075) | 2.89311039 |
| 92 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.87594651 |
| 93 | regulation of antigen processing and presentation (GO:0002577) | 2.87373965 |
| 94 | low-density lipoprotein particle clearance (GO:0034383) | 2.85907716 |
| 95 | resolution of meiotic recombination intermediates (GO:0000712) | 2.85483416 |
| 96 | positive regulation of granulocyte differentiation (GO:0030854) | 2.85424363 |
| 97 | cytidine metabolic process (GO:0046087) | 2.85109856 |
| 98 | cytidine catabolic process (GO:0006216) | 2.85109856 |
| 99 | cytidine deamination (GO:0009972) | 2.85109856 |
| 100 | granulocyte activation (GO:0036230) | 2.84665510 |
| 101 | keratinocyte development (GO:0003334) | 2.84402725 |
| 102 | sulfate transport (GO:0008272) | 2.82414869 |
| 103 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.81777263 |
| 104 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.81552978 |
| 105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.80739071 |
| 106 | regulation of interleukin-12 production (GO:0032655) | 2.79911381 |
| 107 | regulation of cholesterol storage (GO:0010885) | 2.79673927 |
| 108 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.79196149 |
| 109 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79195998 |
| 110 | retinal rod cell development (GO:0046548) | 2.78692347 |
| 111 | regulation of gamma-delta T cell activation (GO:0046643) | 2.78127288 |
| 112 | DNA deamination (GO:0045006) | 2.77527568 |
| 113 | artery development (GO:0060840) | 2.77506943 |
| 114 | positive regulation of glycolytic process (GO:0045821) | 2.77494758 |
| 115 | hepatocyte apoptotic process (GO:0097284) | 2.77373124 |
| 116 | response to interferon-alpha (GO:0035455) | 2.75967742 |
| 117 | regulation of keratinocyte proliferation (GO:0010837) | 2.75838675 |
| 118 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.74956236 |
| 119 | regulation of pigment cell differentiation (GO:0050932) | 2.74450614 |
| 120 | fatty acid elongation (GO:0030497) | 2.74346106 |
| 121 | DNA dealkylation (GO:0035510) | 2.73618765 |
| 122 | dendritic cell differentiation (GO:0097028) | 2.72791103 |
| 123 | piRNA metabolic process (GO:0034587) | 2.72227971 |
| 124 | regulation of T cell tolerance induction (GO:0002664) | 2.71573718 |
| 125 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.71221118 |
| 126 | macrophage activation involved in immune response (GO:0002281) | 2.70638178 |
| 127 | response to interferon-beta (GO:0035456) | 2.70203508 |
| 128 | negative regulation of interleukin-17 production (GO:0032700) | 2.69065556 |
| 129 | adenosine metabolic process (GO:0046085) | 2.68074030 |
| 130 | defense response to protozoan (GO:0042832) | 2.67440836 |
| 131 | replicative senescence (GO:0090399) | 2.67026839 |
| 132 | cytokine secretion (GO:0050663) | 2.66380516 |
| 133 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.66224867 |
| 134 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.65763908 |
| 135 | natural killer cell differentiation (GO:0001779) | 2.65460358 |
| 136 | DNA double-strand break processing (GO:0000729) | 2.65272360 |
| 137 | negative regulation of phagocytosis (GO:0050765) | 2.63887464 |
| 138 | terpenoid biosynthetic process (GO:0016114) | 2.63581952 |
| 139 | desmosome organization (GO:0002934) | 2.62902640 |
| 140 | pigment cell differentiation (GO:0050931) | 2.61810439 |
| 141 | positive regulation of phosphatase activity (GO:0010922) | 2.60366429 |
| 142 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.59335500 |
| 143 | melanocyte differentiation (GO:0030318) | 2.58624197 |
| 144 | cilium morphogenesis (GO:0060271) | 2.58539784 |
| 145 | cellular response to interferon-beta (GO:0035458) | 2.58275332 |
| 146 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.58104486 |
| 147 | cellular response to growth hormone stimulus (GO:0071378) | 2.57019948 |
| 148 | sphingoid metabolic process (GO:0046519) | 2.55136605 |
| 149 | positive regulation of humoral immune response (GO:0002922) | 2.55069179 |
| 150 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.53961354 |
| 151 | proline transport (GO:0015824) | 2.53671498 |
| 152 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.53531816 |
| 153 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.52979454 |
| 154 | developmental pigmentation (GO:0048066) | 2.52638850 |
| 155 | negative thymic T cell selection (GO:0045060) | 2.51950024 |
| 156 | photoreceptor cell maintenance (GO:0045494) | 2.51907275 |
| 157 | sulfation (GO:0051923) | 2.51823482 |
| 158 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.51109523 |
| 159 | axoneme assembly (GO:0035082) | 2.50424533 |
| 160 | S-adenosylmethionine metabolic process (GO:0046500) | 2.50136369 |
| 161 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.48824750 |
| 162 | response to host immune response (GO:0052572) | 2.48824750 |
| 163 | response to protozoan (GO:0001562) | 2.48608109 |
| 164 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.48569376 |
| 165 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.48430264 |
| 166 | positive regulation of macrophage differentiation (GO:0045651) | 2.48416407 |
| 167 | ubiquinone biosynthetic process (GO:0006744) | 2.48266399 |
| 168 | inner ear receptor cell differentiation (GO:0060113) | 2.47902451 |
| 169 | respiratory burst (GO:0045730) | 2.47305387 |
| 170 | regulation of relaxation of muscle (GO:1901077) | 2.47258242 |
| 171 | pinocytosis (GO:0006907) | 2.47249905 |
| 172 | regulation of response to interferon-gamma (GO:0060330) | 2.47232571 |
| 173 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.47102193 |
| 174 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.46650348 |
| 175 | fucose catabolic process (GO:0019317) | 2.46302564 |
| 176 | L-fucose metabolic process (GO:0042354) | 2.46302564 |
| 177 | L-fucose catabolic process (GO:0042355) | 2.46302564 |
| 178 | regulation of hypersensitivity (GO:0002883) | 2.45853155 |
| 179 | positive regulation of developmental pigmentation (GO:0048087) | 2.44903918 |
| 180 | vascular smooth muscle contraction (GO:0014829) | 2.44862684 |
| 181 | retinal cone cell development (GO:0046549) | 2.44819866 |
| 182 | positive regulation of natural killer cell activation (GO:0032816) | 2.44681468 |
| 183 | cell adhesion mediated by integrin (GO:0033627) | 2.44563553 |
| 184 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.43971920 |
| 185 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.43788571 |
| 186 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.43045695 |
| 187 | B cell receptor signaling pathway (GO:0050853) | 2.42966055 |
| 188 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.42954936 |
| 189 | regulation of memory T cell differentiation (GO:0043380) | 2.42083115 |
| 190 | response to host (GO:0075136) | 2.41796617 |
| 191 | response to host defenses (GO:0052200) | 2.41796617 |
| 192 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.41796617 |
| 193 | genitalia morphogenesis (GO:0035112) | 2.41501285 |
| 194 | regulation of tolerance induction (GO:0002643) | 2.41144298 |
| 195 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.40429090 |
| 196 | definitive hemopoiesis (GO:0060216) | 2.39987490 |
| 197 | regulation of natural killer cell differentiation (GO:0032823) | 2.39911255 |
| 198 | regulation of interferon-beta production (GO:0032648) | 2.39819452 |
| 199 | negative T cell selection (GO:0043383) | 2.39769196 |
| 200 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.39034143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.56821882 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.70491416 |
| 3 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.68113629 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.67786592 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.34463179 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.27300782 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.16944733 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08624108 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03141246 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 3.02021484 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.97682550 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.96322217 |
| 13 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.83622366 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.80119871 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75892734 |
| 16 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.74316371 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.63225243 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56501839 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52166272 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.49483102 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.49337332 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.45610639 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.40256583 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.40220576 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.26641503 |
| 26 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.25359714 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23018974 |
| 28 | * FUS_26573619_Chip-Seq_HEK293_Human | 2.22926259 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.21236323 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.20934748 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18917627 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.18575566 |
| 33 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.12921704 |
| 34 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.10759625 |
| 35 | * ER_23166858_ChIP-Seq_MCF-7_Human | 2.10251461 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.06775672 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03065965 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02427743 |
| 39 | * MYB_26560356_Chip-Seq_TH2_Human | 1.99214824 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.97981839 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.96858321 |
| 42 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.94209394 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.91737321 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.89746965 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.88356703 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87477547 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.86537070 |
| 48 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.86509871 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.84693831 |
| 50 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.84417881 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78229874 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.75056173 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.74835433 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74000925 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.73779953 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71894963 |
| 57 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.70327772 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69288427 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.67960298 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67830008 |
| 61 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.66941554 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61185879 |
| 63 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61170697 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61011632 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59574835 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59389260 |
| 67 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.58690348 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57128112 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.56647930 |
| 70 | STAT3_23295773_ChIP-Seq_U87_Human | 1.56351737 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.55313075 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.55313075 |
| 73 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.53446619 |
| 74 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53220027 |
| 75 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52548894 |
| 76 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52536359 |
| 77 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52302113 |
| 78 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.51506317 |
| 79 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.50796198 |
| 80 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.50181969 |
| 81 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.48484837 |
| 82 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.47830930 |
| 83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.45874681 |
| 84 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.45517561 |
| 85 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45076394 |
| 86 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.44529842 |
| 87 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43384048 |
| 88 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42445564 |
| 89 | MYC_22102868_ChIP-Seq_BL_Human | 1.42426981 |
| 90 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.41278434 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.40884938 |
| 92 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39195983 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39140378 |
| 94 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.36239727 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35760519 |
| 96 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.35444087 |
| 97 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34459400 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.33485029 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32757700 |
| 100 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32747603 |
| 101 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32299935 |
| 102 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32060428 |
| 103 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31800582 |
| 104 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.30877833 |
| 105 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29616259 |
| 106 | TCF4_23295773_ChIP-Seq_U87_Human | 1.29173405 |
| 107 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29115664 |
| 108 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.28997960 |
| 109 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28550479 |
| 110 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.28006493 |
| 111 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27126705 |
| 112 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27126705 |
| 113 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27034854 |
| 114 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26939351 |
| 115 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26867601 |
| 116 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25954340 |
| 117 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.25776749 |
| 118 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.25360202 |
| 119 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24224220 |
| 120 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.23987103 |
| 121 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23708904 |
| 122 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.23361290 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23297436 |
| 124 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22790546 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21751684 |
| 126 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19288703 |
| 127 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18923338 |
| 128 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17971558 |
| 129 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17938985 |
| 130 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17643343 |
| 131 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17643343 |
| 132 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.17536738 |
| 133 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17454713 |
| 134 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16868294 |
| 135 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16564018 |
| 136 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15982115 |
| 137 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15518617 |
| 138 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14036505 |
| 139 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13807906 |
| 140 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13627736 |
| 141 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13267525 |
| 142 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.12811931 |
| 143 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12723307 |
| 144 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12681367 |
| 145 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12388037 |
| 146 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12278469 |
| 147 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.12043473 |
| 148 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12037915 |
| 149 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.12029510 |
| 150 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11956602 |
| 151 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11834418 |
| 152 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11510309 |
| 153 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11452428 |
| 154 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11316492 |
| 155 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.10899651 |
| 156 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09982891 |
| 157 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09612117 |
| 158 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09612117 |
| 159 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08670578 |
| 160 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08547626 |
| 161 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08016344 |
| 162 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07448054 |
| 163 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06063855 |
| 164 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05702639 |
| 165 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05403138 |
| 166 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04925124 |
| 167 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04600858 |
| 168 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02520630 |
| 169 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02399592 |
| 170 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.02359822 |
| 171 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00049663 |
| 172 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99249490 |
| 173 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99108129 |
| 174 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98436519 |
| 175 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98148061 |
| 176 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97646534 |
| 177 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97587721 |
| 178 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96442006 |
| 179 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94106500 |
| 180 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93689537 |
| 181 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93239274 |
| 182 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92438554 |
| 183 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91837993 |
| 184 | MAF_26560356_Chip-Seq_TH2_Human | 0.91275696 |
| 185 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90453337 |
| 186 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90409340 |
| 187 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89204102 |
| 188 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87192030 |
| 189 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86014512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.95059183 |
| 2 | MP0000427_abnormal_hair_cycle | 3.44208471 |
| 3 | MP0000372_irregular_coat_pigmentation | 3.43442657 |
| 4 | MP0005075_abnormal_melanosome_morpholog | 3.24785008 |
| 5 | MP0000383_abnormal_hair_follicle | 3.12978639 |
| 6 | MP0010678_abnormal_skin_adnexa | 3.00572018 |
| 7 | MP0000685_abnormal_immune_system | 2.97370875 |
| 8 | MP0001986_abnormal_taste_sensitivity | 2.83033064 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.74824241 |
| 10 | MP0002095_abnormal_skin_pigmentation | 2.54134821 |
| 11 | MP0009785_altered_susceptibility_to | 2.52954448 |
| 12 | MP0005671_abnormal_response_to | 2.48079643 |
| 13 | MP0003436_decreased_susceptibility_to | 2.46244256 |
| 14 | MP0005387_immune_system_phenotype | 2.38378084 |
| 15 | MP0001790_abnormal_immune_system | 2.38378084 |
| 16 | MP0004147_increased_porphyrin_level | 2.37562951 |
| 17 | MP0005171_absent_coat_pigmentation | 2.31875131 |
| 18 | MP0001800_abnormal_humoral_immune | 2.30903250 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.28063251 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.27883292 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.26303027 |
| 22 | MP0003303_peritoneal_inflammation | 2.25042372 |
| 23 | MP0002419_abnormal_innate_immunity | 2.22504669 |
| 24 | MP0003724_increased_susceptibility_to | 2.22232505 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.20066578 |
| 26 | MP0006082_CNS_inflammation | 2.17470550 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 2.15225777 |
| 28 | MP0003300_gastrointestinal_ulcer | 2.10520419 |
| 29 | MP0008775_abnormal_heart_ventricle | 2.10295061 |
| 30 | MP0005025_abnormal_response_to | 2.09547910 |
| 31 | MP0002723_abnormal_immune_serum | 2.02753549 |
| 32 | MP0004484_altered_response_of | 2.01730318 |
| 33 | MP0001819_abnormal_immune_cell | 1.91565538 |
| 34 | MP0000015_abnormal_ear_pigmentation | 1.91395277 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.91240535 |
| 36 | MP0008438_abnormal_cutaneous_collagen | 1.88480186 |
| 37 | MP0002006_tumorigenesis | 1.83900055 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.83665403 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.80917223 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.77854235 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.76911947 |
| 42 | MP0004043_abnormal_pH_regulation | 1.72885344 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.68503550 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.68456080 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.68456080 |
| 46 | MP0001853_heart_inflammation | 1.66922882 |
| 47 | MP0000647_abnormal_sebaceous_gland | 1.66528822 |
| 48 | MP0004215_abnormal_myocardial_fiber | 1.64640159 |
| 49 | MP0010234_abnormal_vibrissa_follicle | 1.64387940 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.64049272 |
| 51 | MP0004947_skin_inflammation | 1.63188001 |
| 52 | MP0004510_myositis | 1.61942842 |
| 53 | MP0002398_abnormal_bone_marrow | 1.54123386 |
| 54 | MP0002822_catalepsy | 1.53731713 |
| 55 | MP0002405_respiratory_system_inflammati | 1.53602436 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.52701078 |
| 57 | MP0000716_abnormal_immune_system | 1.52549400 |
| 58 | MP0001873_stomach_inflammation | 1.50668688 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.50640318 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.46233383 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.46209486 |
| 62 | MP0002254_reproductive_system_inflammat | 1.42535563 |
| 63 | MP0008057_abnormal_DNA_replication | 1.41274452 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.36396589 |
| 65 | MP0004084_abnormal_cardiac_muscle | 1.35714526 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.32719616 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.32276293 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.32232382 |
| 69 | MP0003718_maternal_effect | 1.32078461 |
| 70 | MP0009840_abnormal_foam_cell | 1.32077802 |
| 71 | MP0005076_abnormal_cell_differentiation | 1.31204666 |
| 72 | MP0008469_abnormal_protein_level | 1.30566908 |
| 73 | MP0003448_altered_tumor_morphology | 1.27351342 |
| 74 | MP0002429_abnormal_blood_cell | 1.27310110 |
| 75 | MP0004885_abnormal_endolymph | 1.26697014 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 1.25869952 |
| 77 | MP0003195_calcinosis | 1.25776000 |
| 78 | MP0005503_abnormal_tendon_morphology | 1.25002763 |
| 79 | MP0005253_abnormal_eye_physiology | 1.24931630 |
| 80 | MP0004381_abnormal_hair_follicle | 1.24820019 |
| 81 | MP0002722_abnormal_immune_system | 1.24722778 |
| 82 | MP0003566_abnormal_cell_adhesion | 1.24566334 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 1.23245354 |
| 84 | MP0010386_abnormal_urinary_bladder | 1.22394968 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 1.22378950 |
| 86 | MP0003136_yellow_coat_color | 1.20416295 |
| 87 | MP0002933_joint_inflammation | 1.20279975 |
| 88 | MP0009764_decreased_sensitivity_to | 1.18906632 |
| 89 | MP0003763_abnormal_thymus_physiology | 1.18240240 |
| 90 | MP0003091_abnormal_cell_migration | 1.15798230 |
| 91 | MP0000569_abnormal_digit_pigmentation | 1.15652330 |
| 92 | MP0002938_white_spotting | 1.15614917 |
| 93 | MP0001348_abnormal_lacrimal_gland | 1.15431288 |
| 94 | MP0000377_abnormal_hair_follicle | 1.15250343 |
| 95 | MP0009278_abnormal_bone_marrow | 1.14911302 |
| 96 | MP0005395_other_phenotype | 1.13299586 |
| 97 | MP0002098_abnormal_vibrissa_morphology | 1.12894348 |
| 98 | MP0010307_abnormal_tumor_latency | 1.12284917 |
| 99 | MP0002075_abnormal_coat/hair_pigmentati | 1.11497687 |
| 100 | MP0001958_emphysema | 1.08947317 |
| 101 | MP0006054_spinal_hemorrhage | 1.07681528 |
| 102 | MP0001764_abnormal_homeostasis | 1.06235480 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 1.06153106 |
| 104 | MP0005248_abnormal_Harderian_gland | 1.05399175 |
| 105 | MP0002168_other_aberrant_phenotype | 1.04860989 |
| 106 | MP0003283_abnormal_digestive_organ | 1.04397997 |
| 107 | MP0000613_abnormal_salivary_gland | 1.03395530 |
| 108 | MP0002234_abnormal_pharynx_morphology | 1.02880370 |
| 109 | MP0003567_abnormal_fetal_cardiomyocyte | 1.00366563 |
| 110 | MP0008877_abnormal_DNA_methylation | 1.00317490 |
| 111 | MP0000858_altered_metastatic_potential | 1.00147974 |
| 112 | MP0004036_abnormal_muscle_relaxation | 0.99135935 |
| 113 | MP0006072_abnormal_retinal_apoptosis | 0.98251343 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.98145184 |
| 115 | MP0001879_abnormal_lymphatic_vessel | 0.97523967 |
| 116 | MP0000343_altered_response_to | 0.95494414 |
| 117 | MP0002998_abnormal_bone_remodeling | 0.95012414 |
| 118 | MP0003279_aneurysm | 0.94323310 |
| 119 | MP0003828_pulmonary_edema | 0.94312313 |
| 120 | MP0002796_impaired_skin_barrier | 0.93657774 |
| 121 | MP0005408_hypopigmentation | 0.93466991 |
| 122 | MP0008004_abnormal_stomach_pH | 0.93459540 |
| 123 | MP0003941_abnormal_skin_development | 0.93188258 |
| 124 | MP0005023_abnormal_wound_healing | 0.89893713 |
| 125 | MP0005389_reproductive_system_phenotype | 0.88982110 |
| 126 | MP0002837_dystrophic_cardiac_calcinosis | 0.88415765 |
| 127 | MP0005310_abnormal_salivary_gland | 0.88267150 |
| 128 | MP0001919_abnormal_reproductive_system | 0.88043644 |
| 129 | MP0000490_abnormal_crypts_of | 0.86239960 |
| 130 | MP0003252_abnormal_bile_duct | 0.85939490 |
| 131 | MP0002876_abnormal_thyroid_physiology | 0.85584402 |
| 132 | MP0003890_abnormal_embryonic-extraembry | 0.85215675 |
| 133 | MP0009763_increased_sensitivity_to | 0.85070065 |
| 134 | MP0000371_diluted_coat_color | 0.84544844 |
| 135 | MP0001851_eye_inflammation | 0.83342749 |
| 136 | MP0001666_abnormal_nutrient_absorption | 0.82704105 |
| 137 | MP0000538_abnormal_urinary_bladder | 0.81842996 |
| 138 | MP0001186_pigmentation_phenotype | 0.81516894 |
| 139 | MP0005390_skeleton_phenotype | 0.81282848 |
| 140 | MP0000249_abnormal_blood_vessel | 0.80841850 |
| 141 | MP0001915_intracranial_hemorrhage | 0.79406495 |
| 142 | MP0004782_abnormal_surfactant_physiolog | 0.78840193 |
| 143 | MP0009384_cardiac_valve_regurgitation | 0.78647235 |
| 144 | MP0000609_abnormal_liver_physiology | 0.78525285 |
| 145 | MP0001324_abnormal_eye_pigmentation | 0.78235083 |
| 146 | MP0003075_altered_response_to | 0.77782348 |
| 147 | MP0000703_abnormal_thymus_morphology | 0.77554047 |
| 148 | MP0005365_abnormal_bile_salt | 0.77296231 |
| 149 | MP0003045_fibrosis | 0.76071461 |
| 150 | MP0002136_abnormal_kidney_physiology | 0.75799760 |
| 151 | MP0004134_abnormal_chest_morphology | 0.75269569 |
| 152 | MP0001216_abnormal_epidermal_layer | 0.75055607 |
| 153 | MP0005275_abnormal_skin_tensile | 0.74515835 |
| 154 | MP0003806_abnormal_nucleotide_metabolis | 0.73319101 |
| 155 | MP0002009_preneoplasia | 0.72296656 |
| 156 | MP0005257_abnormal_intraocular_pressure | 0.71825019 |
| 157 | MP0005167_abnormal_blood-brain_barrier | 0.71235693 |
| 158 | MP0001661_extended_life_span | 0.70119419 |
| 159 | MP0003795_abnormal_bone_structure | 0.69541266 |
| 160 | MP0000230_abnormal_systemic_arterial | 0.69511855 |
| 161 | MP0001243_abnormal_dermal_layer | 0.69273815 |
| 162 | MP0005360_urolithiasis | 0.69117622 |
| 163 | MP0004924_abnormal_behavior | 0.68985006 |
| 164 | MP0005386_behavior/neurological_phenoty | 0.68985006 |
| 165 | MP0005595_abnormal_vascular_smooth | 0.68860500 |
| 166 | MP0002102_abnormal_ear_morphology | 0.68445489 |
| 167 | MP0005083_abnormal_biliary_tract | 0.68344671 |
| 168 | MP0005620_abnormal_muscle_contractility | 0.68145189 |
| 169 | MP0003186_abnormal_redox_activity | 0.68100285 |
| 170 | MP0001485_abnormal_pinna_reflex | 0.67233938 |
| 171 | MP0005165_increased_susceptibility_to | 0.65849154 |
| 172 | MP0003787_abnormal_imprinting | 0.65186516 |
| 173 | MP0009115_abnormal_fat_cell | 0.64764157 |
| 174 | MP0001191_abnormal_skin_condition | 0.62604603 |
| 175 | MP0001765_abnormal_ion_homeostasis | 0.61842368 |
| 176 | MP0004145_abnormal_muscle_electrophysio | 0.61503003 |
| 177 | MP0002972_abnormal_cardiac_muscle | 0.60850117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.72321008 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.37563778 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.17445097 |
| 4 | Hematochezia (HP:0002573) | 4.05419057 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.79497737 |
| 6 | True hermaphroditism (HP:0010459) | 3.57995609 |
| 7 | Pancreatic cysts (HP:0001737) | 3.51727145 |
| 8 | Myocardial infarction (HP:0001658) | 3.50492653 |
| 9 | Myositis (HP:0100614) | 3.45331135 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.35171780 |
| 11 | Renal cortical cysts (HP:0000803) | 3.33015700 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.30916128 |
| 13 | Osteolytic defects of the hand bones (HP:0009699) | 3.23596799 |
| 14 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.23596799 |
| 15 | Generalized hypopigmentation of hair (HP:0011358) | 3.20062447 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.17760081 |
| 17 | Abnormality of the renal cortex (HP:0011035) | 3.15861312 |
| 18 | Recurrent viral infections (HP:0004429) | 3.15611718 |
| 19 | Pancreatic fibrosis (HP:0100732) | 3.12296621 |
| 20 | Molar tooth sign on MRI (HP:0002419) | 3.12292372 |
| 21 | Abnormality of midbrain morphology (HP:0002418) | 3.12292372 |
| 22 | Vasculitis (HP:0002633) | 3.07223477 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.07126792 |
| 24 | Fair hair (HP:0002286) | 3.04600570 |
| 25 | Recurrent skin infections (HP:0001581) | 3.03160605 |
| 26 | Arterial thrombosis (HP:0004420) | 3.03060692 |
| 27 | Abnormality of secondary sexual hair (HP:0009888) | 3.02574200 |
| 28 | Abnormality of the axillary hair (HP:0100134) | 3.02574200 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 3.02265779 |
| 30 | Disinhibition (HP:0000734) | 2.98269330 |
| 31 | Thrombocytosis (HP:0001894) | 2.96671955 |
| 32 | Recurrent bronchitis (HP:0002837) | 2.94542377 |
| 33 | Periodontitis (HP:0000704) | 2.93462127 |
| 34 | Orchitis (HP:0100796) | 2.87060217 |
| 35 | Furrowed tongue (HP:0000221) | 2.87045219 |
| 36 | Conjunctival hamartoma (HP:0100780) | 2.85489752 |
| 37 | Chronic otitis media (HP:0000389) | 2.85371196 |
| 38 | Nephronophthisis (HP:0000090) | 2.84360428 |
| 39 | Chronic hepatic failure (HP:0100626) | 2.83054791 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.74545892 |
| 41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.72420795 |
| 42 | Hyperventilation (HP:0002883) | 2.71703417 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 2.70652297 |
| 44 | Ketoacidosis (HP:0001993) | 2.70145435 |
| 45 | Widely spaced teeth (HP:0000687) | 2.70134780 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.70004852 |
| 47 | Optic neuritis (HP:0100653) | 2.70004852 |
| 48 | Autoimmune thrombocytopenia (HP:0001973) | 2.68308169 |
| 49 | Decreased circulating renin level (HP:0003351) | 2.66665896 |
| 50 | Large for gestational age (HP:0001520) | 2.65132422 |
| 51 | Abnormality of the renal medulla (HP:0100957) | 2.64690048 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.63476303 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.63217288 |
| 54 | Cellulitis (HP:0100658) | 2.61966780 |
| 55 | Abnormality of vitamin B metabolism (HP:0004340) | 2.61580498 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.58685041 |
| 57 | Peritonitis (HP:0002586) | 2.56049785 |
| 58 | Congenital stationary night blindness (HP:0007642) | 2.54988803 |
| 59 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.53193280 |
| 60 | Congenital sensorineural hearing impairment (HP:0008527) | 2.52245065 |
| 61 | Hamartoma of the eye (HP:0010568) | 2.51863611 |
| 62 | Abnormal biliary tract morphology (HP:0012440) | 2.51596113 |
| 63 | Abnormality of the nasal mucosa (HP:0000433) | 2.50875064 |
| 64 | Decreased central vision (HP:0007663) | 2.48480810 |
| 65 | Gingival bleeding (HP:0000225) | 2.48114741 |
| 66 | Gastrointestinal stroma tumor (HP:0100723) | 2.46780806 |
| 67 | Abnormality of T cell number (HP:0011839) | 2.46223009 |
| 68 | Abolished electroretinogram (ERG) (HP:0000550) | 2.43821885 |
| 69 | Loss of speech (HP:0002371) | 2.42206006 |
| 70 | Nasal polyposis (HP:0100582) | 2.41455986 |
| 71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.40905535 |
| 72 | Vertebral compression fractures (HP:0002953) | 2.40797319 |
| 73 | Methylmalonic acidemia (HP:0002912) | 2.36909307 |
| 74 | Right ventricular cardiomyopathy (HP:0011663) | 2.35491139 |
| 75 | Esophageal varix (HP:0002040) | 2.35393138 |
| 76 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.35261248 |
| 77 | Aortic aneurysm (HP:0004942) | 2.34657916 |
| 78 | Medial flaring of the eyebrow (HP:0010747) | 2.33496698 |
| 79 | Inflammation of the large intestine (HP:0002037) | 2.33152531 |
| 80 | Keratoconus (HP:0000563) | 2.32883075 |
| 81 | Increased corneal curvature (HP:0100692) | 2.32883075 |
| 82 | Colitis (HP:0002583) | 2.32657876 |
| 83 | Pustule (HP:0200039) | 2.32219368 |
| 84 | Syncope (HP:0001279) | 2.31383841 |
| 85 | Glomerulonephritis (HP:0000099) | 2.31163699 |
| 86 | IgM deficiency (HP:0002850) | 2.30892712 |
| 87 | Subacute progressive viral hepatitis (HP:0006572) | 2.30159545 |
| 88 | Osteomyelitis (HP:0002754) | 2.29981315 |
| 89 | Stomatitis (HP:0010280) | 2.28055070 |
| 90 | T lymphocytopenia (HP:0005403) | 2.26771858 |
| 91 | Gastrointestinal inflammation (HP:0004386) | 2.24076467 |
| 92 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23758536 |
| 93 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23758536 |
| 94 | Meningitis (HP:0001287) | 2.22429293 |
| 95 | Aortic dissection (HP:0002647) | 2.21843838 |
| 96 | Pulmonary infiltrates (HP:0002113) | 2.21400521 |
| 97 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.21210673 |
| 98 | Pheochromocytoma (HP:0002666) | 2.19624703 |
| 99 | Palmar hyperkeratosis (HP:0010765) | 2.18408543 |
| 100 | Emphysema (HP:0002097) | 2.18278613 |
| 101 | Metabolic alkalosis (HP:0200114) | 2.18170935 |
| 102 | Gingivitis (HP:0000230) | 2.17646643 |
| 103 | Leukocytosis (HP:0001974) | 2.14749825 |
| 104 | Blue irides (HP:0000635) | 2.14043808 |
| 105 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13748559 |
| 106 | Obstructive lung disease (HP:0006536) | 2.13748559 |
| 107 | Abnormality of alanine metabolism (HP:0010916) | 2.11599129 |
| 108 | Hyperalaninemia (HP:0003348) | 2.11599129 |
| 109 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.11599129 |
| 110 | Cone-rod dystrophy (HP:0000548) | 2.10843724 |
| 111 | Gaze-evoked nystagmus (HP:0000640) | 2.10125894 |
| 112 | Viral hepatitis (HP:0006562) | 2.09396148 |
| 113 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.09002411 |
| 114 | Tubulointerstitial nephritis (HP:0001970) | 2.08196028 |
| 115 | Lymphopenia (HP:0001888) | 2.07771763 |
| 116 | Abnormality of T cells (HP:0002843) | 2.07676919 |
| 117 | Abnormal platelet volume (HP:0011876) | 2.07284785 |
| 118 | Alopecia of scalp (HP:0002293) | 2.07161496 |
| 119 | Attenuation of retinal blood vessels (HP:0007843) | 2.06343837 |
| 120 | Congenital, generalized hypertrichosis (HP:0004540) | 2.05120367 |
| 121 | Epistaxis (HP:0000421) | 2.04489564 |
| 122 | Abnormality of methionine metabolism (HP:0010901) | 2.04357587 |
| 123 | IgA deficiency (HP:0002720) | 2.04318554 |
| 124 | Congenital hepatic fibrosis (HP:0002612) | 2.03957120 |
| 125 | Protrusio acetabuli (HP:0003179) | 2.03855716 |
| 126 | Nephritis (HP:0000123) | 2.03323395 |
| 127 | Palpitations (HP:0001962) | 2.02672988 |
| 128 | Thyroiditis (HP:0100646) | 2.01742881 |
| 129 | Curly hair (HP:0002212) | 2.01391822 |
| 130 | Hyperactive renin-angiotensin system (HP:0000841) | 2.01203180 |
| 131 | Stomach cancer (HP:0012126) | 1.99962790 |
| 132 | Chronic diarrhea (HP:0002028) | 1.99647773 |
| 133 | Ketosis (HP:0001946) | 1.99310614 |
| 134 | Hemoptysis (HP:0002105) | 1.99111873 |
| 135 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.98886638 |
| 136 | Abnormality of T cell physiology (HP:0011840) | 1.98615006 |
| 137 | Recurrent pneumonia (HP:0006532) | 1.98331089 |
| 138 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.97815577 |
| 139 | Increased mean platelet volume (HP:0011877) | 1.96923746 |
| 140 | Cutaneous melanoma (HP:0012056) | 1.96476892 |
| 141 | Tachypnea (HP:0002789) | 1.95403445 |
| 142 | Gonadotropin excess (HP:0000837) | 1.95091443 |
| 143 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93139594 |
| 144 | Facial diplegia (HP:0001349) | 1.93021315 |
| 145 | Autoimmune hemolytic anemia (HP:0001890) | 1.92685115 |
| 146 | Dysostosis multiplex (HP:0000943) | 1.92201406 |
| 147 | Methylmalonic aciduria (HP:0012120) | 1.91068931 |
| 148 | Neuroendocrine neoplasm (HP:0100634) | 1.90143083 |
| 149 | Premature rupture of membranes (HP:0001788) | 1.89867378 |
| 150 | Keratoconjunctivitis sicca (HP:0001097) | 1.89696758 |
| 151 | Mucosal telangiectasiae (HP:0100579) | 1.88656151 |
| 152 | Agammaglobulinemia (HP:0004432) | 1.88210828 |
| 153 | Hypoplastic labia majora (HP:0000059) | 1.88007923 |
| 154 | Tetraparesis (HP:0002273) | 1.87965747 |
| 155 | Fatigue (HP:0012378) | 1.87466715 |
| 156 | Woolly hair (HP:0002224) | 1.86811637 |
| 157 | Postaxial foot polydactyly (HP:0001830) | 1.86708060 |
| 158 | Abnormality of the lumbar spine (HP:0100712) | 1.86587175 |
| 159 | Pulmonary embolism (HP:0002204) | 1.86247423 |
| 160 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.85636193 |
| 161 | Hypoplasia of the fovea (HP:0007750) | 1.85636193 |
| 162 | Abnormality of complement system (HP:0005339) | 1.85263670 |
| 163 | Palmoplantar hyperkeratosis (HP:0000972) | 1.84842829 |
| 164 | Hypergammaglobulinemia (HP:0010702) | 1.83260528 |
| 165 | Recurrent lower respiratory tract infections (HP:0002783) | 1.82893900 |
| 166 | Eosinophilia (HP:0001880) | 1.82663024 |
| 167 | Petechiae (HP:0000967) | 1.81621492 |
| 168 | Thyroid carcinoma (HP:0002890) | 1.81523057 |
| 169 | Macular degeneration (HP:0000608) | 1.81322186 |
| 170 | Protruding tongue (HP:0010808) | 1.79898000 |
| 171 | Biliary tract neoplasm (HP:0100574) | 1.79758860 |
| 172 | Chest pain (HP:0100749) | 1.79093995 |
| 173 | Polycythemia (HP:0001901) | 1.78447084 |
| 174 | Cystic liver disease (HP:0006706) | 1.77196604 |
| 175 | Complement deficiency (HP:0004431) | 1.77190089 |
| 176 | Plantar hyperkeratosis (HP:0007556) | 1.76328084 |
| 177 | Constricted visual fields (HP:0001133) | 1.75445455 |
| 178 | Papillary thyroid carcinoma (HP:0002895) | 1.74348041 |
| 179 | Abnormality of renin-angiotensin system (HP:0000847) | 1.71180076 |
| 180 | Portal hypertension (HP:0001409) | 1.70843217 |
| 181 | Albinism (HP:0001022) | 1.70265036 |
| 182 | Abnormality of the labia majora (HP:0012881) | 1.70063235 |
| 183 | Congenital primary aphakia (HP:0007707) | 1.67952027 |
| 184 | Erythroderma (HP:0001019) | 1.64074203 |
| 185 | Hemiparesis (HP:0001269) | 1.63594715 |
| 186 | Follicular hyperkeratosis (HP:0007502) | 1.62927462 |
| 187 | Hip dysplasia (HP:0001385) | 1.62500518 |
| 188 | Genital tract atresia (HP:0001827) | 1.62046812 |
| 189 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.61259287 |
| 190 | Premature loss of primary teeth (HP:0006323) | 1.59609084 |
| 191 | Onycholysis (HP:0001806) | 1.59364132 |
| 192 | Clitoromegaly (HP:0000057) | 1.58057816 |
| 193 | Abnormal hair laboratory examination (HP:0003328) | 1.57956405 |
| 194 | Breast carcinoma (HP:0003002) | 1.55901453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.53407600 |
| 2 | BMPR1B | 3.15636262 |
| 3 | EIF2AK3 | 3.14526474 |
| 4 | TYK2 | 3.02916003 |
| 5 | ACVR1B | 3.01929036 |
| 6 | STK38L | 2.84904497 |
| 7 | MAP4K1 | 2.70495628 |
| 8 | TGFBR2 | 2.55948982 |
| 9 | TBK1 | 2.53753939 |
| 10 | JAK3 | 2.49524172 |
| 11 | BLK | 2.40596339 |
| 12 | IKBKB | 2.24229465 |
| 13 | KIT | 2.21459634 |
| 14 | STK10 | 2.12697732 |
| 15 | JAK1 | 2.08981125 |
| 16 | MAP4K2 | 2.05725544 |
| 17 | MKNK2 | 2.02247379 |
| 18 | MKNK1 | 1.90107574 |
| 19 | FRK | 1.89437180 |
| 20 | IKBKE | 1.87011834 |
| 21 | GRK1 | 1.81441801 |
| 22 | LRRK2 | 1.75934409 |
| 23 | CSF1R | 1.72122589 |
| 24 | FGFR3 | 1.69114562 |
| 25 | RIPK4 | 1.68861911 |
| 26 | MST1R | 1.68431466 |
| 27 | MAP3K10 | 1.64908885 |
| 28 | PIK3CA | 1.61108586 |
| 29 | CHUK | 1.61078295 |
| 30 | ZAP70 | 1.59997157 |
| 31 | PBK | 1.57105523 |
| 32 | STK39 | 1.56850460 |
| 33 | RPS6KA4 | 1.56554589 |
| 34 | MAPK13 | 1.53053615 |
| 35 | FGFR4 | 1.52833593 |
| 36 | EPHB1 | 1.52385016 |
| 37 | BTK | 1.51904477 |
| 38 | AKT3 | 1.51451229 |
| 39 | NEK9 | 1.50147719 |
| 40 | IRAK4 | 1.50075921 |
| 41 | NUAK1 | 1.49757710 |
| 42 | MST4 | 1.49648683 |
| 43 | TRIB3 | 1.47729037 |
| 44 | EPHA3 | 1.45647337 |
| 45 | PKN2 | 1.41053939 |
| 46 | PRKD3 | 1.40257885 |
| 47 | TEC | 1.37048573 |
| 48 | IRAK3 | 1.35142964 |
| 49 | MAPKAPK3 | 1.34978132 |
| 50 | CSK | 1.34344431 |
| 51 | PTK6 | 1.34126829 |
| 52 | FLT3 | 1.33745628 |
| 53 | STK3 | 1.31574362 |
| 54 | PIM1 | 1.26784396 |
| 55 | ITK | 1.26755355 |
| 56 | ERN1 | 1.21510055 |
| 57 | MAPKAPK5 | 1.19361305 |
| 58 | TRPM7 | 1.17558193 |
| 59 | TTN | 1.17367849 |
| 60 | TNIK | 1.16976478 |
| 61 | LCK | 1.14387615 |
| 62 | FER | 1.14346293 |
| 63 | TGFBR1 | 1.13671088 |
| 64 | MAP3K13 | 1.11226482 |
| 65 | CAMKK2 | 1.10024613 |
| 66 | PDK2 | 1.05251343 |
| 67 | JAK2 | 1.03238023 |
| 68 | OBSCN | 1.00962407 |
| 69 | TXK | 1.00332754 |
| 70 | ADRBK2 | 0.99857173 |
| 71 | CDK6 | 0.99087999 |
| 72 | ZAK | 0.98807485 |
| 73 | KDR | 0.97796980 |
| 74 | EEF2K | 0.96375097 |
| 75 | WNK3 | 0.95316203 |
| 76 | TRIM28 | 0.94762976 |
| 77 | PRKCE | 0.92930619 |
| 78 | PAK3 | 0.92488386 |
| 79 | SYK | 0.91735422 |
| 80 | STK4 | 0.91127491 |
| 81 | MARK3 | 0.88868895 |
| 82 | INSRR | 0.88799643 |
| 83 | TAF1 | 0.88193283 |
| 84 | LYN | 0.88185068 |
| 85 | HCK | 0.84595826 |
| 86 | MAPK7 | 0.84040676 |
| 87 | NEK6 | 0.83931308 |
| 88 | NME2 | 0.83111935 |
| 89 | CSNK1G2 | 0.81474275 |
| 90 | PRKAA2 | 0.81245682 |
| 91 | MAP3K4 | 0.80260912 |
| 92 | BMPR2 | 0.77707605 |
| 93 | MAP3K8 | 0.77534140 |
| 94 | CSNK1G1 | 0.77124283 |
| 95 | TAOK3 | 0.76105290 |
| 96 | MET | 0.75998125 |
| 97 | RIPK1 | 0.74757717 |
| 98 | VRK1 | 0.74392657 |
| 99 | OXSR1 | 0.74182753 |
| 100 | LATS1 | 0.70779124 |
| 101 | PIM2 | 0.70457290 |
| 102 | NLK | 0.70116913 |
| 103 | CCNB1 | 0.68083016 |
| 104 | MAP2K3 | 0.67759906 |
| 105 | ABL1 | 0.66852684 |
| 106 | STK24 | 0.65531771 |
| 107 | SCYL2 | 0.63070161 |
| 108 | TIE1 | 0.61183139 |
| 109 | SIK1 | 0.60316251 |
| 110 | CDK4 | 0.59789839 |
| 111 | EIF2AK1 | 0.58717423 |
| 112 | PLK2 | 0.58594658 |
| 113 | STK38 | 0.58463857 |
| 114 | CDK9 | 0.57837282 |
| 115 | MATK | 0.56632828 |
| 116 | MELK | 0.55756305 |
| 117 | CSNK1A1L | 0.55220627 |
| 118 | FGFR2 | 0.55079620 |
| 119 | BCKDK | 0.54507308 |
| 120 | EIF2AK2 | 0.53150760 |
| 121 | BRSK2 | 0.53082741 |
| 122 | YES1 | 0.52365986 |
| 123 | MYLK | 0.52077392 |
| 124 | BMX | 0.50782403 |
| 125 | MAPKAPK2 | 0.50426313 |
| 126 | MOS | 0.50151381 |
| 127 | PRKCQ | 0.49070648 |
| 128 | PIK3CG | 0.48543643 |
| 129 | PLK3 | 0.47799222 |
| 130 | CSNK1G3 | 0.47067025 |
| 131 | PAK4 | 0.46894273 |
| 132 | RPS6KA5 | 0.46505675 |
| 133 | EGFR | 0.45497678 |
| 134 | CLK1 | 0.45481975 |
| 135 | ERBB3 | 0.44777425 |
| 136 | IGF1R | 0.44269782 |
| 137 | PRKD2 | 0.40907311 |
| 138 | ABL2 | 0.40685120 |
| 139 | GSK3A | 0.38731021 |
| 140 | GRK6 | 0.38456037 |
| 141 | IRAK1 | 0.37971860 |
| 142 | BCR | 0.37930275 |
| 143 | SGK2 | 0.37269621 |
| 144 | WEE1 | 0.35078940 |
| 145 | PTK2B | 0.34155750 |
| 146 | WNK4 | 0.34142623 |
| 147 | MAP3K3 | 0.33932793 |
| 148 | INSR | 0.33756126 |
| 149 | ADRBK1 | 0.31822625 |
| 150 | FGR | 0.31381197 |
| 151 | HIPK2 | 0.30704003 |
| 152 | TNK2 | 0.30528650 |
| 153 | ATM | 0.29102102 |
| 154 | ERBB2 | 0.27144107 |
| 155 | DMPK | 0.25853360 |
| 156 | TLK1 | 0.25644424 |
| 157 | NEK1 | 0.23213373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.37861850 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.03734924 |
| 3 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.91340917 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.83643644 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64784912 |
| 6 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.59261548 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.54078430 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43798003 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.36845297 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.36125598 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.27898738 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.25081235 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.22920942 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.14095925 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09761763 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07389369 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.07075068 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04625460 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 2.02637755 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01955974 |
| 21 | Measles_Homo sapiens_hsa05162 | 2.00592413 |
| 22 | Malaria_Homo sapiens_hsa05144 | 2.00002454 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.99393058 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.94024532 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92347902 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.92075560 |
| 27 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.85637521 |
| 28 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.84519520 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.84304770 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79890229 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.79379674 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.76034361 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.74610450 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.70975011 |
| 35 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.69091746 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67934313 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65291442 |
| 38 | Mineral absorption_Homo sapiens_hsa04978 | 1.61387341 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.57321326 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.53288708 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51871712 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51101267 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50577636 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.50061812 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.49987587 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49558335 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.45291043 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.45288788 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44430931 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 1.43017985 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.42730924 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.40749642 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38129038 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35102724 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34791564 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34499544 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 1.32722461 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32058244 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.30236342 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28803404 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 1.19950982 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.19756403 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 1.18984696 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18231511 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18178878 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17235038 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.17041563 |
| 68 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.16117467 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14469960 |
| 70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.12937382 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.12265930 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 1.12071050 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08684970 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08013016 |
| 75 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07702119 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05995016 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04939686 |
| 78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04655914 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04241789 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03856942 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03321242 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00953811 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.99075409 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95793879 |
| 85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.94264684 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93242479 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.92448216 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92409061 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.92335084 |
| 90 | Asthma_Homo sapiens_hsa05310 | 0.90941678 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.90605975 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89701633 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89700431 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85129444 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.83110792 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82864851 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80444361 |
| 98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79679712 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79402781 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.75023206 |
| 101 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74628352 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73990371 |
| 103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72583275 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72462330 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.71846336 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71080884 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71001402 |
| 108 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.70657994 |
| 109 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70023386 |
| 110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69250453 |
| 111 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69081567 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68243899 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67606089 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66518208 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66463663 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66397319 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66074887 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65838599 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.64785447 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64601634 |
| 121 | RNA degradation_Homo sapiens_hsa03018 | 0.64373700 |
| 122 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61178531 |
| 123 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60615922 |
| 124 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59495223 |
| 125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56929227 |
| 126 | Phototransduction_Homo sapiens_hsa04744 | 0.56829951 |
| 127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56254298 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54521078 |
| 129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53900961 |
| 130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53677780 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52682743 |
| 132 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52485666 |
| 133 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.51601380 |
| 134 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51388394 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.50803124 |
| 136 | Adherens junction_Homo sapiens_hsa04520 | 0.50572818 |
| 137 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50517891 |
| 138 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49949004 |
| 139 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47760596 |
| 140 | Taste transduction_Homo sapiens_hsa04742 | 0.47721951 |
| 141 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45308441 |
| 142 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44745745 |
| 143 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42918196 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42369923 |
| 145 | ABC transporters_Homo sapiens_hsa02010 | 0.42241213 |
| 146 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40309689 |
| 147 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38633433 |
| 148 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36824314 |
| 149 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36329659 |
| 150 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36048781 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35191020 |
| 152 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33943115 |
| 153 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33710663 |
| 154 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.32770846 |
| 155 | Endocytosis_Homo sapiens_hsa04144 | 0.32617893 |
| 156 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.31368328 |
| 157 | Prostate cancer_Homo sapiens_hsa05215 | 0.30724447 |
| 158 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30618120 |
| 159 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.30144571 |
| 160 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.28760028 |
| 161 | Histidine metabolism_Homo sapiens_hsa00340 | 0.27359350 |
| 162 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26355333 |
| 163 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25803363 |
| 164 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25741145 |
| 165 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25537766 |
| 166 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.24174313 |
| 167 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23304721 |

